Continuous subcutaneous insulin infusion (CSII) in inpatient setting: unmet needs and the proposal of a CSII unit

Dario Pitocco, Andrea Giaccari, Alessandra Lauria, Lelio Morviducci, Alessandra Di Flaviani, Angelo Lauria, Paolo Pozzilli, Concetta Suraci, Simona Frontoni

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)

Abstract

Continuous subcutaneous insulin infusion (CSII) represents an increasingly popular method of treating diabetes. Patients with diabetes are often hospitalized, and current data indicate that inpatient hyperglycemia results in poorer outcomes. When patients on insulin pump therapy require hospitalization, practitioners caring for them face the issue of how to manage the inpatient care of these patients. We believe that patients using insulin pumps can safely have their therapy transitioned when hospitalized. Moreover, CSII during hospitalization should be regarded not only as a fundamental tool in patients already on insulin pump therapy, but also as an effective method to obtain euglycemia, in critically ill patients. However, a standard policy on CSII use during hospitalization is still lacking, and literature data are inconclusive about the benefits of insulin pump on glycemic homeostasis, in hospitalized patients. We suggest that a CSII unit should be activated inside the hospital, in order to increase compliance with required procedures and to properly address the unmet needs of CSII in inpatient setting.
Original languageEnglish
Pages (from-to)1071-1074
Number of pages4
JournalDIABETES TECHNOLOGY & THERAPEUTICS
Volume13
DOIs
Publication statusPublished - 2011

Keywords

  • GLYCEMIA
  • INSULIN INFUSION

Fingerprint

Dive into the research topics of 'Continuous subcutaneous insulin infusion (CSII) in inpatient setting: unmet needs and the proposal of a CSII unit'. Together they form a unique fingerprint.

Cite this